Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?

ESMO Open

Department of Oncology and Hematology, University of Milano, Milan; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy. Electronic address:

Published: September 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11415669PMC
http://dx.doi.org/10.1016/j.esmoop.2024.103695DOI Listing

Publication Analysis

Top Keywords

immunotherapy treatment
4
treatment landscape
4
landscape hormone
4
hormone receptor-positive
4
receptor-positive hr+
4
hr+ early
4
early breast
4
breast cancer
4
cancer data
4
data clinical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!